These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 9782579

  • 21. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [Abstract] [Full Text] [Related]

  • 22. Azathioprine dose escalation in inflammatory bowel disease.
    Rayner CK, Hart AL, Hayward CM, Emmanuel AV, Kamm MA.
    Aliment Pharmacol Ther; 2004 Jul 01; 20(1):65-71. PubMed ID: 15225172
    [Abstract] [Full Text] [Related]

  • 23. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM, Iser JH, Gibson PR.
    J Gastroenterol Hepatol; 2008 Jun 01; 23(6):954-8. PubMed ID: 17559377
    [Abstract] [Full Text] [Related]

  • 24. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun 01; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 25. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F, Wagner AC, Göke B.
    Schweiz Med Wochenschr; 2000 Feb 19; 130(7):222-32. PubMed ID: 10719713
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.
    Okamura S, Aoki H, Ohashi S, Urano F, Shimodaira M, Kanamori S, Ishikawa H, Segawa K.
    Hepatogastroenterology; 2003 Feb 19; 50(49):91-4. PubMed ID: 12629999
    [Abstract] [Full Text] [Related]

  • 27. The state of the art in the management of inflammatory bowel disease.
    Hanauer SB, Present DH.
    Rev Gastroenterol Disord; 2003 Feb 19; 3(2):81-92. PubMed ID: 12776005
    [Abstract] [Full Text] [Related]

  • 28. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul 19; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

  • 29. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ, Tremaine WJ, Lawson GM.
    Am J Gastroenterol; 1996 Jan 19; 91(1):37-43. PubMed ID: 8561141
    [Abstract] [Full Text] [Related]

  • 30. [Cyclosporin in an oral microemulsion as the initial treatment of corticoid-refractory ulcerative colitis].
    Ortiz V, Nos P, Aguilera V, Berenguer J, Ponce J.
    Gastroenterol Hepatol; 2000 Mar 19; 23(3):120-2. PubMed ID: 10804688
    [Abstract] [Full Text] [Related]

  • 31. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM.
    J Pediatr; 2000 Dec 19; 137(6):794-9. PubMed ID: 11113835
    [Abstract] [Full Text] [Related]

  • 32. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 33. Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis.
    Actis GC, Lagget M, Rizzetto M, Fadda M, Palmo A, Pinna-Pintor M, Morino F.
    Minerva Med; 2004 Feb 15; 95(1):65-70. PubMed ID: 15041927
    [Abstract] [Full Text] [Related]

  • 34. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D, Katsanos K, Baltayannis G, Tzabouras N, Tsianos EV.
    Hepatogastroenterology; 2003 Feb 15; 50(52):1021-4. PubMed ID: 12845970
    [Abstract] [Full Text] [Related]

  • 35. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
    Hanauer SB, Smith MB.
    Am J Gastroenterol; 1993 May 15; 88(5):646-9. PubMed ID: 8480725
    [Abstract] [Full Text] [Related]

  • 36. Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators.
    Feagan BG, McDonald JW, Rochon J, Laupacis A, Fedorak RN, Kinnear D, Saibil F, Groll A, Archambault A, Gillies R.
    N Engl J Med; 1994 Jun 30; 330(26):1846-51. PubMed ID: 8196727
    [Abstract] [Full Text] [Related]

  • 37. Therapeutical experiments in ulcerative colitis and Crohn's disease.
    Nagy G, Prónay G, Ujszászy L.
    Acta Med Hung; 1985 Jun 30; 42(3-4):163-74. PubMed ID: 2869469
    [Abstract] [Full Text] [Related]

  • 38. Immunosuppression in inflammatory bowel disease: traditional, biological or both?
    Van Assche G, Vermeire S, Rutgeerts P.
    Curr Opin Gastroenterol; 2009 Jul 30; 25(4):323-8. PubMed ID: 19417645
    [Abstract] [Full Text] [Related]

  • 39. Cyclosporin for severe ulcerative colitis attacks.
    Danalioglu A, Kaymakoglu S, Mungan Z, Karaca C, Demir K, Durakoglu Z, Besisik F, Boztas G, Cakaloglu Y, Okyen A.
    Hepatogastroenterology; 2003 Dec 30; 50 Suppl 2():ccxcviii-ccc. PubMed ID: 15244207
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
    Sands BE.
    Gut; 2006 Apr 30; 55(4):437-41. PubMed ID: 16531519
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.